Pays: Nouvelle-Zélande
Langue: anglais
Source: Medsafe (Medicines Safety Authority)
Teicoplanin 400mg
Pharmacy Retailing (NZ) Ltd t/a Healthcare Logistics
Teicoplanin 400 mg
400 mg
Powder for injection with diluent
Active: Teicoplanin 400mg Excipient: Sodium chloride Sodium hydroxide Water for injection
Ampoule, glass, 1 x 3.0, 3 mL
Prescription
Prescription
sanofi-aventis SpA
Package - Contents - Shelf Life: Ampoule, glass, - 3 mL - 60 months from date of manufacture stored at or below 25°C - Combination pack, 1 x (powder + diluent) - 400 mg - 36 months from date of manufacture stored at or below 25°C 24 hours reconstituted stored at 2° to 8°C (Refrigerate, do not freeze) - Vial, glass, - 400 mg - 36 months from date of manufacture stored at or below 25°C
1991-08-27
TARGOCID® 1 TARGOCID ® CONSUMER MEDICINE INFORMATION (CMI) SUMMARY The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. 1. WHY AM I BEING GIVEN TARGOCID? Targocid contains the active ingredient teicoplanin. Targocid injection is an antibiotic. It is used to kill bacteria responsible for infections which can occur in your blood, bones or joints. For more information, see Section 1. Why am I being given Targocid? in the full CMI. 2. WHAT SHOULD I KNOW BEFORE I AM GIVEN TARGOCID? Do not use if you have ever had an allergic reaction to Targocid or any of the ingredients listed at the end of the CMI. TALK TO YOUR DOCTOR IF YOU HAVE ANY OTHER MEDICAL CONDITIONS, TAKE ANY OTHER MEDICINES, ARE PREGNANT OR PLAN TO BECOME PREGNANT, OR ARE BREASTFEEDING OR PLANNING TO BREASTFEED. For more information, see Section 2. What should I know before I am given Targocid? in the full CMI. What if I am taking other medicines? 3. WHAT IF I AM TAKING OTHER MEDICINES? Some medicines may interfere with Targocid and affect how it works. A list of these medicines is in Section 3. What if I am taking other medicines? in the full CMI. 4. HOW WILL I BE GIVEN TARGOCID? • Targocid injection should be prepared and administered by a qualified health professional (doctor, pharmacist or nurse). More instructions can be found in Section 4. How will I be given Targocid? in the full CMI. 5. WHAT SHOULD I KNOW WHILE BEING GIVEN TARGOCID? THINGS YOU SHOULD DO • Call your doctor straight away if you notice any symptoms of serious skin reactions, including blistering of your skin, mouth, eyes or genitals, a red scaly widespread rash and blisters accompanied by a fever, or flu-like symptoms and a rash on your face and body with a fever. • Remind any doctor, dentist or pharmacist that you visit that you are being given Targocid. THINGS YOU SHOULD NOT DO • Do not receive more than the recommended dose unless your doctor or pharmacist tells you to. • Do not stop receiving Lire le document complet
targocid-ccdsv5-dsv9-03mar23 1 NEW ZEALAND DATA SHEET 1 PRODUCT NAME Targocid 400 mg lyophilised powder for injection with water for injections ampoule. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each vial contains 400mg teicoplanin equivalent to not less than 400,000 IU. For full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Teicoplanin lyophilised powder for injections is an off-white, odourless powder contained in a vial of 20 mL (400 mg) together with ampoules of water for injections. The final solution is isotonic with plasma and has a pH of 7.2 -7.8. See section 6.6. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Targocid is indicated in adults and in children from 2 months for the treatment of the following serious infections due to staphylococci or streptococci, which cannot be treated satisfactorily with less toxic agents including beta-lactam antibiotics:- Bone - osteomyelitis Joint - septic arthritis Blood - non-cardiac bacteraemia, septicaemia 4.2 DOSE AND METHOD OF ADMINISTRATION Teicoplanin can be administered either intravenously or intramuscularly. Intravenous dosing may be by rapid injection over 3-5 minutes, or more slowly over a 30 minute infusion. An intramuscular injection of teicoplanin should not exceed 3 mL (400 mg) at a single site. For instructions on reconstitution of the medicine before administration see Section 6.6. Dosage is usually once daily following an initial loading dose which is administered as three 12hourly doses on the first day of therapy. The dose is to be adjusted on body weight whatever the weight of the patient. targocid-ccdsv5-dsv9-03mar23 2 The majority of patients with infections caused by organisms sensitive to the antibiotic show a therapeutic response within 48-72 hours. The total duration of therapy is determined by the type and severity of the infection and the clinical response of the patient. The following periods are often appropriate: • Uncomplicated bacteraemia 2-4 weeks • Septic arthritis or osteomyelitis 3-6 weeks The use of teicopl Lire le document complet